Drug Free Solution Inc.

As of February 28, 2014, Drug Free Solution Inc. carries a market capitalization of 9.70M, placing it among publicly traded companies globally. Its enterprise value stands at 9.70M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of February 28, 2014, Drug Free Solution Inc. has 35.94M shares outstanding.

These figures are as of February 28, 2014. The price-to-sales ratio is 9,468.05, and the price-to-book ratio stands at -28.61.

These figures are as of February 28, 2014. The EV/Sales ratio of 4,615.64 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 9.70M versus a market cap of 9.70M, with the gap driven by net debt and cash on the balance sheet.

As of February 28, 2014, Drug Free Solution Inc. maintains a current ratio of 0.02, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended February 28, 2014. Return on assets (ROA) is negative at -2,032.09, reflecting losses generated across the asset base.

As of the close on July 17, 2026, Drug Free Solution Inc.'s stock has gained approximately 100.00% over the past 52 weeks. The 50-day moving average sits at 0.04, while the 200-day moving average is 0.11.

Over the twelve months ended February 28, 2014, Drug Free Solution Inc. generated 2,101.00 in revenue and converted that into -867,712.00 in net income, yielding earnings per share of -0.01. EBITDA reached -862,274.00, while operating income came in at -867,712.00.

These figures are as of February 28, 2014. Total book value stands at -339,231.00, with working capital of -384,362.00 providing operational flexibility.

Drug Free Solution Inc. produced -735,452.00 in operating cash flow over the twelve months ended February 28, 2014. After subtracting 12,340.00 in capital expenditures, free cash flow totaled -723,112.00 - equivalent to -0.01 per share.

Over the twelve months ended February 28, 2014, Drug Free Solution Inc. posted a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -41,299.95 and net profit margin of -41,299.95 provide insight into operational efficiency.

These figures cover the twelve months ended February 28, 2014. Free cash flow yield is negative at -3.64: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -7.64, meaning Drug Free Solution Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Drug Free Solution Inc.'s most recent stock split took place on January 9, 2014 with a 1:3 split ratio.

As of February 28, 2014, Drug Free Solution Inc. has an Altman Z-Score of -120.34, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.